相关实验视频

Updated: Jul 5, 2025

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons

Published on: January 7, 2019

在安德森-法布里疾病中,中枢和周围神经系统并发症的分子病原体

Antonino Tuttolomondo^1,2, Irene Baglio^1,2, Renata Riolo^1,2

¹Department of Health Promotion, Maternal and Infant Care, Internal Medicine and Medical Specialties, "G. D'Alessandro", University of Palermo, Piazza delle Cliniche n.2, 90127 Palermo, Italy.

International journal of molecular sciences

|January 11, 2024

概括

费布里病涉及到全球基胺的积累,通过各种分子机制引起神经损伤. 目前正在进行研究,以寻找生物标志物,以便更好地诊断和监测治疗.

科学领域:

神经学神经学
遗传学遗传学是一个
生物化学生物化学

背景情况:

法布里病 (FD) 是一种由α-银酸酶A (GLA) 基因突变引起的单一性疾病.
GLA基因突变导致全球基胺 (Gb3) 在 lysosomes 中积累,影响包括神经系统在内的多个器官.
神经学表现包括外围神经病变,自主功能障碍和脑血管事件.

研究的目的:

审查在法布里病中潜在的外周和中央神经系统并发症的分子机制.
突出Gb3积累,炎症,氧化应激和神经退行症中亡的作用.
讨论新生物标志物在疾病管理中的潜力.

主要方法:

在法布里病神经系统并发症中的分子机制的文献综述.
对Gb3积累,炎症,氧化应激和亡途径的分析.
对法布里病的现有和新兴生物标志物研究的评估.

主要成果:

Gb3的积累直接导致外围神经受损.
中枢神经系统的参与是与小血管疾病相关的脑血管事件的特征.
炎症,氧化应激和改变的亡途径都与FD病变发生有关.
酶替代疗法对亡相关蛋白质的影响需要进一步研究.

结论:

在法布里病中,神经系统的并发症来自于不同的分子路径.
确定可靠的生物标志物对于改善诊断,疾病监测和治疗反应评估至关重要.
目前正在进行的蛋白质和代谢学研究旨在发现用于管理法布里病的新生物标志物.

关键词:

安德森法布里病的疾病.银河系酸酶-阿尔法酶是什么神经系统神经系统神经系统这是外围的外围.

更多相关视频

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

Published on: June 15, 2018

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

Published on: June 25, 2019

相关概念视频

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.